MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $152,000 | +44.8% | 2,525 | +9.9% | 0.00% | 0.0% |
| Q1 2016 | $105,000 | -16.0% | 2,297 | -10.9% | 0.00% | 0.0% |
| Q4 2015 | $125,000 | +9.6% | 2,579 | -4.1% | 0.00% | 0.0% |
| Q3 2015 | $114,000 | -36.0% | 2,688 | +72.1% | 0.00% | -33.3% |
| Q2 2015 | $178,000 | -0.6% | 1,562 | +12.7% | 0.00% | 0.0% |
| Q1 2015 | $179,000 | +27.9% | 1,386 | -1.1% | 0.00% | 0.0% |
| Q4 2014 | $140,000 | +115.4% | 1,401 | +113.6% | 0.00% | +50.0% |
| Q3 2014 | $65,000 | +132.1% | 656 | +77.8% | 0.00% | +100.0% |
| Q2 2014 | $28,000 | +7.7% | 369 | -8.7% | 0.00% | 0.0% |
| Q1 2014 | $26,000 | +30.0% | 404 | +29.9% | 0.00% | 0.0% |
| Q4 2013 | $20,000 | +150.0% | 311 | +139.2% | 0.00% | – |
| Q3 2013 | $8,000 | +14.3% | 130 | 0.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $186,908,000 | 79.34% |
| Redmile Group, LLC | 1,752,642 | $74,487,000 | 5.64% |
| APIS CAPITAL ADVISORS, LLC | 93,500 | $3,974,000 | 5.50% |
| March Altus Capital Management LP | 18,794 | $799,000 | 4.71% |
| HealthCor Management, L.P. | 1,900,000 | $80,750,000 | 4.55% |
| BB BIOTECH AG | 2,581,112 | $109,697,000 | 3.48% |
| Selkirk Management LLC | 116,000 | $4,930,000 | 3.06% |
| Opus Point Partners Management, LLC | 118,372 | $5,031,000 | 2.78% |
| TORRAY INVESTMENT PARTNERS LLC | 797,015 | $33,873,000 | 2.49% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 3,772,600 | $160,336,000 | 1.78% |